A recent study suggests that GLP-1 obesity treatments may reduce the risk of various cancers. While researchers continue investigating, early studies show positive correlations between these medications and decreased risk in breast, liver, colorectal, and lung cancer, potentially due to weight reduction and anti-inflammatory effects. These findings, while promising, are still preliminary and further research is needed to confirm their efficacy as treatments for cancer.
Original Article Source Link:
https://www.npr.org/2026/06/09/nx-s1-5850732/glp-1-cancer-asco-semaglutide-tirezepatide